Literature DB >> 26837056

Likelihood ratio meta-analysis: New motivation and approach for an old method.

Colin R Dormuth1, Kristian B Filion2, Robert W Platt3.   

Abstract

A 95% confidence interval (CI) in an updated meta-analysis may not have the expected 95% coverage. If a meta-analysis is simply updated with additional data, then the resulting 95% CI will be wrong because it will not have accounted for the fact that the earlier meta-analysis failed or succeeded to exclude the null. This situation can be avoided by using the likelihood ratio (LR) as a measure of evidence that does not depend on type-1 error. We show how an LR-based approach, first advanced by Goodman, can be used in a meta-analysis to pool data from separate studies to quantitatively assess where the total evidence points. The method works by estimating the log-likelihood ratio (LogLR) function from each study. Those functions are then summed to obtain a combined function, which is then used to retrieve the total effect estimate, and a corresponding 'intrinsic' confidence interval. Using as illustrations the CAPRIE trial of clopidogrel versus aspirin in the prevention of ischemic events, and our own meta-analysis of higher potency statins and the risk of acute kidney injury, we show that the LR-based method yields the same point estimate as the traditional analysis, but with an intrinsic confidence interval that is appropriately wider than the traditional 95% CI. The LR-based method can be used to conduct both fixed effect and random effects meta-analyses, it can be applied to old and new meta-analyses alike, and results can be presented in a format that is familiar to a meta-analytic audience.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Likelihood ratio; Meta-analysis; Meta-analytic methods

Mesh:

Substances:

Year:  2016        PMID: 26837056      PMCID: PMC5705233          DOI: 10.1016/j.cct.2016.01.008

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  20 in total

Review 1.  Approaches to heterogeneity in meta-analysis.

Authors:  D B Petitti
Journal:  Stat Med       Date:  2001-12-15       Impact factor: 2.373

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 3.  Uncertainty in heterogeneity estimates in meta-analyses.

Authors:  John P A Ioannidis; Nikolaos A Patsopoulos; Evangelos Evangelou
Journal:  BMJ       Date:  2007-11-03

4.  The statistical basis of public policy: a paradigm shift is overdue.

Authors:  R J Lilford; D Braunholtz
Journal:  BMJ       Date:  1996-09-07

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Statistical criteria in the interpretation of epidemiologic data.

Authors:  W D Thompson
Journal:  Am J Public Health       Date:  1987-02       Impact factor: 9.308

7.  Beyond the confidence interval.

Authors:  C Poole
Journal:  Am J Public Health       Date:  1987-02       Impact factor: 9.308

8.  Are all significant P values created equal? The analogy between diagnostic tests and clinical research.

Authors:  W S Browner; T B Newman
Journal:  JAMA       Date:  1987-05-08       Impact factor: 56.272

9.  Significance tests have a role in epidemiologic research: reactions to A. M. Walker.

Authors:  J L Fleiss
Journal:  Am J Public Health       Date:  1986-05       Impact factor: 9.308

10.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

View more
  1 in total

1.  The Association Between Hypertensive Disorders in Pregnancy and the Risk of Developing Chronic Hypertension.

Authors:  Jiahao Xu; Ting Li; Yixiao Wang; Lu Xue; Zhijing Miao; Wei Long; Kaipeng Xie; Chen Hu; Hongjuan Ding
Journal:  Front Cardiovasc Med       Date:  2022-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.